會員登入
![<?php echo $Lang["title"]; ?>](images/logo.svg){kind=logo}
出版品
結核醫訊第56期（113年12月出刊）
2024年度
2024/12/16
新知導讀
- Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomized, controlled, phase 2B-3, multi-arm, multicenter, non-inferiority trial
- High-Dose Isoniazid acks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized Phase II Clinical Trial
- Prevalence of tuberculosis infection among contacts of drug-resistant tuberculosis patients: A systematic review and meta-analysis
- Effectiveness and safety of tuberculosis preventive treatment for contacts of patients with multidrug-resistant tuberculosis: a systematic review and meta-analysis
- Prevalence of subclinical pulmonary tuberculosis in adults in community settings: an individual participant data meta-analysis
學術專欄
- 支氣管鏡技術在結核病診斷與治療的應用 – 陳姵辛技術師/陳崇裕醫師
- 結核病的免疫治療 – 梁晨醫師、唐神結醫師、林明貴醫師
- 高齡病人罹患鳥型分枝桿菌肺病治療的臨床挑戰與治療策略 – 劉持瑜專科護理師、樹金忠醫師
- 潛伏結核感染預防性治療處方之副作用和完成率的探討 – 張育平醫師
研討會摘要
